TL;DR: MSOs like GTBIF and CURLF dominate U.S. cannabis but trade OTC. Canadian LPs like TLRY and CGC trade on NASDAQ/NYSE with broader institutional access. Each has a different risk/reward profile. Track them all at weedstock.com/tracker/.
Why the MSO vs LP Divide Matters
The cannabis investment landscape is split into two fundamentally different categories: U.S. Multi-State Operators (MSOs) and Canadian Licensed Producers (LPs). These companies operate under entirely different legal frameworks, capital market structures, and competitive dynamics. Understanding the divide is essential before allocating capital to either category.
MSOs operate in the United States where cannabis remains federally illegal. LPs operate in Canada where cannabis has been federally legal since 2018. That single policy difference creates cascading effects on everything from stock exchange listings to tax treatment to who can invest in these companies.
The Top U.S. MSOs
Green Thumb Industries (GTBIF)
Green Thumb is consistently viewed as one of the most financially disciplined operators in the U.S. cannabis sector. Headquartered in Chicago, the company operates the RISE Dispensaries brand across multiple states including Illinois, Pennsylvania, New Jersey, and Nevada. GTBIF has been one of the few cannabis companies to consistently generate positive free cash flow — a rarity in the sector. Its conservative capital allocation strategy and premium positioning have made it a relative outperformer in institutional cannabis portfolios.
Curaleaf Holdings (CURLF)
Curaleaf is one of the largest cannabis companies by revenue in the world, operating dispensaries and cultivation sites across the U.S. and with a growing European presence. The company pursues an aggressive growth strategy, expanding into new domestic and international markets. While Curaleaf’s scale is substantial, investors should note its debt load and the profitability challenges that come with operating at such breadth. CURLF trades on the OTCQX.
Trulieve Cannabis Corp (TCNNF)
Trulieve built its foundation as the dominant cannabis retailer in Florida, capturing significant market share in the state. After acquiring Harvest Health, Trulieve expanded into Arizona, Pennsylvania, and other markets. Florida’s retail cannabis market — the largest in the Southeast — remains central to Trulieve’s investment thesis. Investors watching TCNNF pay close attention to Florida market dynamics, including competitive pressure as new operators enter the state.
The Top Canadian LPs
Tilray Brands (TLRY)
Tilray Brands trades on NASDAQ, making it accessible to a broader range of institutional investors than OTC-traded MSOs. The company has evolved beyond pure cannabis into alcohol and wellness, with brands like SweetWater Brewing and a significant medical cannabis export business. Tilray’s diversification strategy is either a hedge against cannabis headwinds or a distraction from its core, depending on who you ask — but it gives the company revenue streams unavailable to most cannabis-only companies.
OrganiGram Holdings (OGI)
OrganiGram is a New Brunswick-based LP that has carved out a strong position in value cannabis products in Canada. Known for its innovative cultivation technology and consistent improvement in per-gram production costs, OGI is often cited as one of the better-run Canadian LPs from an operational efficiency standpoint. The company has been expanding into the UK and European medical markets. British American Tobacco’s stake in OGI has given it a degree of legitimacy and capital access unusual for a Canadian LP.
Canopy Growth Corp (CGC)
Canopy Growth was once the most valuable cannabis company in the world, riding a wave of hype and Constellation Brands’ billion-dollar investment. Since then, it has undergone significant restructuring, divested multiple brands, and is attempting to pivot toward the U.S. market — which it cannot directly enter while cannabis remains federally illegal. Canopy’s U.S. option structure gives it a path to acquire U.S. assets upon federal legalization, but the timeline for that trigger remains uncertain. CGC trades on NASDAQ and remains one of the most widely held cannabis stocks by retail investors.
MSO vs LP: The Investment Tradeoffs
| Factor | U.S. MSOs | Canadian LPs |
|---|---|---|
| Exchange Listing | OTC Markets (OTCQX/Pink) | NASDAQ / NYSE |
| Federal Legal Status | Federally illegal (U.S.) | Federally legal (Canada) |
| 280E Tax Burden | Yes — major earnings drag | No |
| Market Size | $30B+ U.S. market | ~$5B Canadian market |
| Institutional Access | Limited (OTC) | Broader (exchange-listed) |
| Rescheduling Upside | Very high | Moderate (via U.S. expansion) |
Tracking These Companies
The performance of these companies shifts daily based on earnings reports, regulatory developments, and broader market conditions. For live price data and analysis on all major cannabis tickers, visit the Weedstock Cannabis Stock Tracker — the resource built specifically for cannabis market intelligence.
Whether you lean toward U.S. MSOs for their domestic market upside or Canadian LPs for their exchange listing and liquidity profile, the key is understanding why you’re making that choice. Each category rewards different investor profiles and risk tolerances.